FibroGen May Have A New Opening For Roxadustat In The US

 
• By Jessica Merrill

The company announced positive Phase II data for roxadustat in chemotherapy-induced anemia.

Two Roads
FibroGen could have another path to take forward for roxadustat • Source: Alamy

More from Blood and Clotting

More from Therapy Areas